Return to Homepage
Promoting Excellence in Education, Research, and Patient Care in the Rapidly Evolving Management of Gastrointestinal Cancer International Society of Gastrointestinal Oncology - Established 2003
About Us Highlights and News Conferences ISGIO Mentor Program Contact Us
2010 ISGIO Conference
Program Description
Invited Faculty
Scientific Program
Registration Information
Call for Abstracts
Educational Grants
2009 Meeting Review
2008 Meeting Review
ISGIO 2007 Meeting Information
2006 ISGIO Meeting Review
Program Description
2009 Gastrointestinal Oncology Conference
Program Description
The 2010 Gastrointestinal Oncology Conference, the official meeting of the International Society of Gastrointestinal Oncology, will provide an educational forum for presenting and discussing the latest advances in the broad field of GI cancer research, as well as critical issues relevant to the care of persons with GI cancer.
The conference will feature distinguished speakers covering a broad spectrum of topics ranging from basic science to clinical therapeutics. Presenters and discussants will explore current issues and debate controversial topics. Case presentations will be given by the faculty and the audience will participate by an interactive audience response system to stimulate discussion on diagnosis and management. This program should be of interest to professionals actively engaged clinically or scientifically in all facets of GI cancer research and care.
 
Educational Objectives
After attending the Conference, participants will be able to:
•
 Describe current trends in therapy and therapeutic advances in research for various GI cancers.
•
 Identify current and new molecular biological pathways in GI cancers.
•
 Define current trends in the therapy of colorectal cancer in the adjuvant and advanced settings.
•
 Indicate the latest techniques in therapeutic endoscopy and liver cancer ablation.
•
 Determine when surgery is required in the management of localized esophageal cancer.
•
 Differentiate the role of surgery and chemoradiotherapy in the management of resectable gastric cancer.
•
 Recognize the role of radiotherapy in the management of pancreatic cancer.
•
 Discuss the biology of Barrett’s metaplasia and its progression to carcinoma.
 
CME Accreditation
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Nebraska, Center for Continuing Education and Letters & Sciences and the International Society of Gastrointestinal Oncology.
 
Nursing Continuing Education
Letters & Sciences is an approved provider of continuing nursing education by the New Jersey State Nurses Association (NJSNA), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider Number P205-5/07-10. 
Letters & Sciences is also an approved provider by the California Board of Registered Nursing, Provider Number CEP14145. 
This activity has been designated for 10.25 contact hours. 
 
 
©2009 International Society of Gastrointestinal Oncology